Controlled Drugs and Substances Act

Sche dule

1
opioids amphetamines

2
cannabis

3
methylphenidate

4
barbiturates benzodiazepines

5

6
Class Precursors Pseudoephedrine ephedrine ergotamine

7
cannabi s 3 kg

8
cannibis 30g

anabolic steroids

Benzodiazepines and Other Targeted Substances
-A pharmacist may, in accordance with this Part, compound a targeted substance pursuant to a prescription.
If a pharmacist receives a targeted substance from a licensed dealer, a pharmacist in another pharmacy or a hospital, the pharmacist must keep a record of the following information:  (a) the brand name  (b) the quantity and strength, the number of units per package and the number of packages;  (c) the name and address of the licensed dealer, pharmacist or hospital that supplied it; and  (d) the date on which it was received. a pharmacist may sell, provide, send, deliver or transport a targeted substance to or for an individual or for the benefit of an animal if  (a) the pharmacist sells or provides the substance in a container labelled ;  (b) the transaction is made pursuant to a prescription o (i) dated and signed by a practitioner, o (ii) provided verbally to the pharmacist by a practitioner, or o (iii) transferred to the pharmacist;  (c) the pharmacist has not transferred the prescription to another pharmacist; and  (d) when the prescription has been provided verbally, the transaction is recorded by the pharmacist A pharmacist who sells or provides a targeted substance to an individual must do so in a container that is labelled with the following information:  (a) name and address of the pharmacy  (b) date of issuance of the prescription and the number given to it by the pharmacist;  (c) the patient name and address  (d) the name of the practitioner who issued the prescription;  (e) the specified name or brand name of the targeted substance;  (f) the quantity, the strength per unit of the targeted substance; and  (g) the directions for use specified by the practitioner. A pharmacist who receives a verbal prescription for a targeted substance must, before filling it,  (a) record the following information: o (i) the name and address of patient o (ii) the date that the verbal prescription was provided, o (iii) the specified name or brand name, o (iv) the quantity, the strength per unit, o (v) the name of the recording pharmacist and the name of the practitioner who issued the

prescription, (vi) the directions for use specified by the practitioner, and (vii) the number of times it may be refilled and, if specified, the interval between refills; and (b) keep a hard copy or create a written record of the prescription.
o o

A pharmacist who fills or refills a prescription for a targeted substance must record the following information:  (a) the date the prescription was filled or refilled;  (b) the quantity of the targeted substance provided at the original filling and at each refill;  (c) the pharmacist’s name or initials; and  (d) the prescription number.

A pharmacist may only refill a prescription for a targeted substance if  (a) the prescriber expressly directs that the prescription may be refilled and specifies the number of    

refills; (b) the pharmacist makes a record of each refill; (c) less than one year has elapsed since the day on which the prescription was issued by the practitioner; (d) at least one refill remains on the prescription; and (e) in the case where an interval between refills has been specified by the practitioner, it has expired.

-A pharmacist may transfer a prescription for a targeted substance to another pharmacist, except a prescription that has already been transferred. Before a pharmacist sells or provides a targeted substance to an individual under a prescription transferred the pharmacist must  (a) in the case of a verbal transfer, record the information;  (b) in the case of a written transfer, have obtained from the transferring pharmacist a copy of o (i) the prescription written by the practitioner, or o (ii) the record made of the practitioner’s verbal prescription; and  (c) in all cases, record o (i) the name and address of the transferring pharmacist, o (ii) the number of authorized refills remaining and, if applicable, the specified interval between o

refills, and (iii) the date of the last refill.

A pharmacist who transfers a prescription must record the date of the transfer, the name of the pharmacist to whom the prescription was transferred, the name and address of the pharmacy where that pharmacist practises and, if applicable, the number of refills that are being transferred. A pharmacist may sell, provide, send, deliver or transport a targeted substance without a prescription to any of the following persons on receipt of an order from that person that specifies the name and quantity of the targeted substance:  (a) if the order is written, a licensed dealer who o (i) sold or provided the targeted substance, or o (ii) is licensed to destroy targeted substances;  (b) subject to subsection (2), o (i) a practitioner, o (ii) another pharmacist, if the other pharmacist states that the targeted substance is required

 

because of a delay or shortfall in an order for the targeted substance placed with a licensed dealer, or o (iii) a hospital, if the order is placed by a pharmacist practising in the hospital or by a practitioner who is authorized to order the targeted substance on behalf of the hospital; (c) the Minister, if the order is a written order signed on the Minister’s behalf; or (d) a person to whom an exemption with respect to the targeted substance has been granted under section 56 of the Act, if the order is a written order and is accompanied by a copy of the exemption.

if the order is verbal, the pharmacist must record the following information:  (a) the name and address of the pharmacist or practitioner placing the order;  (b) if the order was placed on behalf of an establishment, the name and address of the establishment;  (c) the date of the order;  (d) the specified name or the brand name of the targeted substance ordered;  (e) the quantity and, the strength per unit; and  (f) the name of the recording pharmacist. - The pharmacist must keep the written order or, if the order is verbal, must create a hard copy of the order. A pharmacist who closes premises in which a targeted substance has been stored must, not later than 10 days after the closure, inform the Minister of the date of closure, the location to which the targeted substance was moved and the quantity of the targeted substance that was moved .

A pharmacist who does not wish to receive or have possession of targeted substances may make a written request to the Minister to send to licensed dealers and pharmacies a notice, issued under section 79, that states that targeted substances must not be supplied to that pharmacist A pharmacist must not,  (a) sell or provide a targeted substance to a pharmacist or practitioner named in a notice issued under 

section 79; or (b) fill a prescription or order for a targeted substance from a practitioner named in a notice issued under section 79.

Marihuana
A pharmacist, as defined in section 2 of the Narcotic Control Regulations, may provide dried marihuana produced by a licensed dealer under contract with Her Majesty in right of Canada to the holder of an authorization to possess.

Narcotic Control Regulations
A pharmacist, upon receipt of a narcotic from a licensed dealer, shall forthwith enter in a book, register or other record maintained for such purposes, the following:  (a) the name and quantity of the narcotic received;  (b) the date the narcotic was received; and  (c) the name and address of the person from whom the narcotic was received. A pharmacist may sell or provide a narcotic other than methadone to a person  (a) if the person is exempted under section 56 of the Act with respect to the possession of that narcotic; 

or (b) if the pharmacist has first received a written order or prescription therefor signed and dated by a practitioner and the signature of the practitioner, where not known to the pharmacist, has been verified by him.

a pharmacist may sell or provide a narcotic to a midwife, nurse practitioner or podiatrist only if the midwife, nurse practitioner or podiatrist is permitted to prescribe or possess the narcotic, or to conduct an activity with it A pharmacist may sell or provide methadone to  (a) a licensed dealer;  (b) another pharmacist;  (c) a hospital employee;  (c.1) if practising in a hospital, a practitioner of medicine, dentistry or veterinary medicine or a nurse  

practitioner; (d) a person exempted under section 56 of the Act with respect to methadone; or (e) a person from whom the pharmacist has received a written order or prescription signed and dated by a practitioner of medicine who is exempted under section 56 of the Act with respect to methadone.

No pharmacist shall provide or sell a narcotic/narcotic preparation to a pharmacist or practitioner named in the notice issued by the Minister No pharmacist shall dispense or fill a prescription for a narcotic/narcotic preparation from a practitioner named in the Minister’s notice
 Subject to subsection (2), a pharmacist may provide a narcotic to an employee of a hospital or a practitioner in a hospital if the pharmacist receives a written order for the narcotic signed and dated by  (a) the pharmacist in charge of the dispensary of the hospital; or  (b) a practitioner who is authorized by the person in charge of the hospital to order the narcotic and who, in the case of methadone, is exempted under section 56 of the Act with respect to methadone.  Before providing a narcotic, the pharmacist receiving the order must know the signature on the order or verify it. a pharmacist may, without a prescription, sell or provide a preparation containing not more than 8 mg/tablet or not more than 20 mg per 30 mL in a liquid preparation if  (a) the preparation contains

o

o

(i) two additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-half the regular minimum single dose for each such ingredient, or (ii) three additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-third the regular minimum single dose for each such ingredient; and

(b) there is legibly and conspicuously printed on the inner label and the outer label, a caution to the following effect:

“This preparation contains codeine and should not be administered to children except on the advice of a physician, dentist or nurse practitioner.”
No pharmacist shall sell or provide a preparation referred to above if the pharmacist has reasonable grounds to believe that the preparation is to be used for purposes other than recognized medical or dental purposes. Where, pursuant to a written order or prescription, a pharmacist dispenses a narcotic, other than dextropropoxyphene or a verbal prescription narcotic, the pharmacist shall forthwith enter in a book, register or other record maintained for such purposes  (a) the name and address of the person named in the order or prescription;  (b) the name, quantity and form of the narcotic;  (c) the name, initials and address of the practitioner who issued the order or prescription;  (d) the name or initials of the pharmacist who sold or provided the narcotic;  (e) the date on which the narcotic was sold or provided; and  (f) the prescription number. A pharmacist shall, before dispensing a verbal prescription narcotic pursuant to a verbal order or prescription, make a written record thereof, setting forth  (a) the name and address of the person named therein;  (b) the name and quantity of such oral prescription narcotic or the narcotic and the other medicinal ingredients;  (c) the directions for use;  (d) the name, initials and address of the practitioner who issued the order or prescription;  (e) the name or initials of the pharmacist who dispensed such oral prescription narcotic;  (f) the date on which such oral prescription narcotic was sold or provided; and  (g) the prescription number  A pharmacist shall maintain a special narcotic prescription file in which shall be filed in sequence as to date

and number all written orders or prescriptions for narcotics dispensed and the written record of all verbal prescription narcotics dispensed pursuant to a verbal order or prescription.  A pharmacist shall retain in his possession for a period of at least two years any records which he is required to keep by these Regulations. A pharmacist shall report to the Minister any loss or theft of a narcotic within 10 days of his discovery thereof.
 No pharmacist shall prepare a narcotic unless the Minister has approved the formula thereof, and if such narcotic is a preparation described in section 36, has approved the label and the size of the container in which it will be sold.  A pharmacist who prepares a narcotic shall, in addition to all other records required to be kept, keep a record of the following:  (a) the kind and quantity of any narcotic used in the preparation;  (b) the name and quantity of the narcotic prepared; and  (c) the date that the prepared narcotic was placed in stock. A pharmacist shall, immediately after returning, selling or providing a narcotic or after receiving a narcotic, enter the details of the transaction in a book, register or other record maintained for the purpose of recording such transactions. The Minister must issue a notice to the persons and authorities advising them that licensed dealers and pharmacists practising in the notified pharmacies must not sell or provide to the pharmacist named in the notice one or more of the following:  (a) a narcotic, other than a verbal prescription narcotic;  (b) a verbal prescription narcotic, other than a preparation mentioned in section 36; or  (c) a OTC narcotic (8mg codeine tablets).

Precursor Control Regulations
A pharmacist may, pursuant to a prescription, compound a preparation or mixture using a precursor. A pharmacist may sell or provide a preparation or mixture that contains a Class A precursor set out in column 1 of the schedule The prescription must be  (a) written, dated and signed by the practitioner who issued it;  (b) provided verbally by a practitioner; or  (c) transferred to the pharmacist  A pharmacist who receives a VERBAL prescription for a preparation or mixture containing a Class A precursor must, before filling it, record the following information:  (a) the name and address of the individual or owner of the animal for whose benefit the prescription is provided;  (b) the date on which the prescription was provided;  (c) the name and quantity of the preparation or mixture specified in the prescription;  (d) the name of the recording pharmacist and the name of the practitioner who issued the prescription;  (e) the directions for use specified by the practitioner; and  (f) if the prescription is to be refilled, the number of times it may be refilled and, if applicable, the interval between refills.  The pharmacist must retain, in accordance with section 91.95, a hard copy of the prescription or a written record of it.  a pharmacist who fills WRITTEN or verbal prescription for a preparation or mixture containing a Class A precursor must record the following information:  (a) the date the prescription was filled;  (b) the quantity of the preparation or mixture provided when the prescription was filled;  (c) the pharmacist’s name or initials; and  (d) the number assigned to the prescription.  (2) A pharmacist who fills a written prescription shall retain the prescription A pharmacist may only refill a prescription for a preparation or mixture containing a Class A precursor if  (a) the practitioner who issued the prescription expressly directs that it may be refilled and specifies the number of refills;  (b) the pharmacist makes a record of each refill in accordance with subsection, with any modifications that the circumstances require;  (c) at least one refill remains on the prescription; and  (d) if an interval between refills has been specified by the practitioner, the interval has expired.  A pharmacist may transfer a prescription for a preparation or mixture containing a Class A precursor to another pharmacist or to a hospital.  Before a pharmacist sells or provides a preparation or mixture containing a Class A precursor to an individual under a prescription that is transferred under subsection (1), the pharmacist shall  (a) in the case of a verbal transfer, record the information required by subsection 91.4(1);  (b) in the case of a written transfer, obtain from the transferring pharmacist a copy of o (i) the prescription written by the practitioner, or o (ii) the written record, made in accordance with subsection 91.4(2), of the practitioner’s verb al prescription; and  (c) in all cases, record o (i) the name and address of the transferring pharmacist, o (ii) the number of authorized refills remaining and, if applicable, the specified interval between refills, and o (iii) the date of the last refill. A pharmacist, practitioner or hospital that sells or provides only on a retail basis, or possesses for the purpose of sale or provision, preparations or mixtures containing Class A precursors, shall  (a) take reasonable steps to ensure the security of the Class A precursors;

(b) on discovering an unusual waste or disappearance of a Class A precursor that cannot be explained on the basis of normally accepted business practices, notify o (i) a member of a police force within 24 hours after the discovery, and o (ii) the Minister, in writing, within 72 hours after making the discovery

Column 1 Item 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. Precursor set out in Part 1 of Schedule VI to the Act Acetic anhydride N-Acetylanthranilic acid (2-acetamidobenzoic acid) Anthranilic acid (2-aminobenzoic acid) Ephedra Ephedrine (erythro-2-(methylamino)-1-phenyl-propan-1-ol) Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6methylergoline-8-carboxamide) Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman3′,6′,18-trione) Isosafrole (5-(1-propenyl)-1,3-benzodioxole) Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) 3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2propanone) Norephedrine (Phenylpropanolamine) Phenylacetic acid 1-Phenyl-2-propanone Piperidine Piperonal (1,3-benzodioxole-5-carboxaldehyde) Potassium permanganate Pseudoephedrine (threo-2-(methylamino)-1-phenyl-propan-1-ol) Safrole (5-(2-propenyl)-1,3-benzodioxole) Gamma-butyrolactone (dihydro-2(3H)- furanone) 1,4-butanediol Red Phosphorus White Phosphorus Hypophosphorous acid, its salts and derivatives Hydriodic acid

Column 2 Maximum Quantity (expressed as an absolute amount or per package) 1000 kg 1 kg 1 kg 20 g per package 0.4 g per package 0 0 0.5 kg 0 0 0 1 kg 0 0.5 kg 0.5 kg 50 kg 3 g per package 0.25 kg 0 0 0 0 0

Master your semester with Scribd & The New York Times

Special offer for students: Only $4.99/month.

Master your semester with Scribd & The New York Times

Cancel anytime.